CME Group Inc (NASDAQ:CME) CEO Terrence A. Duffy sold 39,309 shares of the company’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $202.38, for a total transaction of $7,955,355.42. Following the completion of the transaction, the chief executive officer now owns 46,684 shares in the company, valued at $9,447,907.92. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

CME traded up $1.45 during trading hours on Friday, hitting $204.59. 894,313 shares of the company’s stock were exchanged, compared to its average volume of 1,487,290. CME Group Inc has a 12-month low of $161.05 and a 12-month high of $224.91. The firm has a 50 day moving average of $203.13 and a 200 day moving average of $205.64. The firm has a market cap of $73.36 billion, a P/E ratio of 30.00, a price-to-earnings-growth ratio of 4.04 and a beta of 0.17. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.14.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.15. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The firm had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the prior year, the firm earned $1.45 EPS. The firm’s revenue for the quarter was up 41.3% on a year-over-year basis. As a group, research analysts expect that CME Group Inc will post 6.87 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Tuesday, December 10th will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.47%. The ex-dividend date is Monday, December 9th. CME Group’s payout ratio is currently 43.99%.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Girard Partners LTD. increased its stake in CME Group by 3.1% during the 2nd quarter. Girard Partners LTD. now owns 4,363 shares of the financial services provider’s stock worth $847,000 after buying an additional 130 shares during the period. Prime Capital Investment Advisors LLC increased its position in shares of CME Group by 59.5% in the 2nd quarter. Prime Capital Investment Advisors LLC now owns 319 shares of the financial services provider’s stock valued at $62,000 after purchasing an additional 119 shares during the last quarter. Doyle Wealth Management purchased a new stake in shares of CME Group in the 2nd quarter valued at approximately $58,000. Caisse DE Depot ET Placement DU Quebec increased its position in shares of CME Group by 28.9% in the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 79,801 shares of the financial services provider’s stock valued at $15,490,000 after purchasing an additional 17,900 shares during the last quarter. Finally, First Trust Advisors LP increased its position in shares of CME Group by 120.1% in the 3rd quarter. First Trust Advisors LP now owns 32,604 shares of the financial services provider’s stock valued at $6,891,000 after purchasing an additional 17,789 shares during the last quarter. 84.27% of the stock is currently owned by hedge funds and other institutional investors.

CME has been the topic of several recent analyst reports. Oppenheimer initiated coverage on shares of CME Group in a report on Monday, September 16th. They issued an “outperform” rating and a $234.00 price objective on the stock. ValuEngine lowered shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Citigroup upped their price objective on shares of CME Group from $220.00 to $240.00 and gave the stock a “buy” rating in a report on Monday, October 21st. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, October 18th. Finally, UBS Group upped their price objective on shares of CME Group from $218.00 to $221.00 and gave the stock a “neutral” rating in a report on Wednesday, December 4th. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the company’s stock. CME Group presently has a consensus rating of “Hold” and an average target price of $207.42.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: CD Ladder

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.